Manuel Varas-Godoy

20PUBLICATIONS
68CO-AUTHORS
Haematological tumoursNatural language processingPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 30, 2026
Lymphodepleting preconditioning impairs host antitumor immunity induced by adoptive T cell therapy in mouse models.

Diego Figueroa, Juan Pablo Vega, Andrés Hernández-Oliveras

|Jan 28, 2026
HPV-18-Immortalised Cells Require the Downregulation of the SncmtRNA-2/Hsa-miR-620 Axis During Cell Transformation.

Emanuel Jeldes, Manuel Varas-Godoy, Paulina González-Chacón

|Nov 05, 2025
HERPUD1 mediates palmitic acid-induced UPR sustaining TNBC aggressiveness and is destabilized by CK2 pharmacological inhibition.

Laura Hernández-Torres, Viviana A Cavieres, Omar Cortés

|Oct 02, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.

Clare Puttick, Thomas P Jones, Michelle M Leung

|Jul 01, 2024
Chemo-small extracellular vesicles released in cisplatin-resistance ovarian cancer cells are regulated by the lysosomal function.

Cristóbal Cerda-Troncoso, Felipe Grünenwald, Eloísa Arias-Muñoz

|Jun 07, 2024
Tumor-derived hypoxic small extracellular vesicles promote endothelial cell migration and tube formation via ALS2/Rab5/β-catenin signaling.

Patricio Silva, Nadia Hernández, Héctor Tapia

Pageof 4

Frequent Collaborators

2 joint publications

Gregory Rice

2 joint publications

Sebastián E Illanes

2 joint publications

Rodrigo A Acuña

2 joint publications

Per Uhlén